Efficacy of an Empowerment-Based, Group-Delivered HIV Prevention Intervention for Young Transgender Women

Authors:

Abstract
For transgender women in the United States, evidence suggests that the prevalence of HIV is very high, including among young transgender women (YTW) aged 16 through 29 years.1,2 A meta-analysis of the burden of HIV infection for transgender women worldwide found that HIV prevalence in the United States was 21.7% (95% CI, 18.4%-25.1%); transgender women had 34-fold increased odds of HIV infection compared with all adults of reproductive age.3 In addition, among more than 500 transgender women tested for HIV infection (with no known previous positive HIV test results) in Miami, Florida, San Francisco, California, and Los Angeles, California, 45% of all new HIV infections were among those aged 20 through 29 years,4 suggesting a particularly high incidence rate among YTW.

This publication has 23 references indexed in Scilit: